Global Antenatal Screening Market Growth (Status and Outlook) 2023-2029

Global Antenatal Screening Market Growth (Status and Outlook) 2023-2029

Antenatal screening refers to the development of the embryo or fetus before birth, whether there are diseases and other aspects of testing diagnosis.

LPI (LP Information)' newest research report, the “Antenatal Screening Industry Forecast” looks at past sales and reviews total world Antenatal Screening sales in 2022, providing a comprehensive analysis by region and market sector of projected Antenatal Screening sales for 2023 through 2029. With Antenatal Screening sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Antenatal Screening industry.

This Insight Report provides a comprehensive analysis of the global Antenatal Screening landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Antenatal Screening portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Antenatal Screening market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Antenatal Screening and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Antenatal Screening.

The global Antenatal Screening market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Antenatal Screening is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Antenatal Screening is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Antenatal Screening is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Antenatal Screening players cover GE, Bio-Rad, Thermo Fisher Scientific, Agilent, Medtronic, ZenTech, Trivitron, PerkinElmer and Natus, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Antenatal Screening market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Amniocentesis
Chorionic Villus Sampling
Ultrasonic Testing
Others

Segmentation by application
Hospital
Specialty Clinic
Diagnostic Center
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
GE
Bio-Rad
Thermo Fisher Scientific
Agilent
Medtronic
ZenTech
Trivitron
PerkinElmer
Natus

Please note: The report will take approximately 2 business days to prepare and deliver.